Building ‘Smart’ Cell-Based Therapies
Synthetic biologist Joshua Leonard and his team have developed a technology for engineering human cells as therapies that become activated only in diseased tissues.
Synthetic biologist Joshua Leonard and his team have developed a technology for engineering human cells as therapies that become activated only in diseased tissues.
With such ambitious goals as helping cure cancer and eradicating pervasive disease, a group of scientists from the emerging field of synthetic biology are breaking new ground at Northwestern University.
Some of the leading minds in synthetic biology assembled in Chicago last month for an international synthetic biology workshop, co-hosted by Northwestern University and the UK Science and Innovation Network.
Northwestern synthetic biology researchers, working with partners at Harvard Medical School, have for the first time synthesized protein-generating cell structures called ribosomes in a test tube.
Professors and graduate students presented research at the sixth annual BioBricks Foundation Synthetic Biology Conference Series in London.
Keith Tyo has been selected as the recipient of the 2013 ISEN Early Career Investigator Award.
The innovative research of Northwestern professors who are making a difference in synthetic biology has been recognized with two early-stage discovery awards from Grand Challenges Explorations, an initiative funded by the Bill & Melinda Gates Foundation.
A team of McCormick students took top honors last month at a regional competition for iGEM, an undergraduate synthetic biology competition.
Jewett will use the award to advance his research on developing cell-free synthetic biology for biomanufacturing new classes of life-saving drugs, sustainable fuels and novel materials from renewable resources.
With the award, Jewett aims to reconceptualize the way we engineer biology for producing next generation materials.